Medicure Inc.

(MPH:PUR)

By |

Profile

Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat and management and growth of Apicore. It has Marketing and distribution of Aggrastat and Manufacturing and distribution of API segments. The firm derives the majority of its revenue geographically from the United States.

Contact Information

Website: www.medicure.com
Email: info@medicure.com
Main Phone: +1 204 487-7412
Address: 2-1250 Waverley Street
State: MB
City / Town: Winnipeg
Country: CAN
Postal Code: R3T 6C6

Issuer Information

Exchange: CDX
CEO: Albert D. Friesen
Employees: 55
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.31 $ 0. (0.00%)
Last Price 7.31 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close 7.31
Last Trade Volume 0 52 Wk Hi 7.65 52 Wk Low 6.06
Market Cap 114.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 15,714,329.00 EPS (TTM) 3.08 PE Ratio 2.00 Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 8.5 8.5 8.5 8.5
Low Target Price Estimate 8.5 8.5 8.5 8.5
Mean Target Price Estimate 8.5 8.5 8.5 8.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/24/18 05/24/18 05/24/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1